These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2436590)

  • 41. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
    Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
    Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
    Sharma RP; Javaid JI; Faull K; Davis JM; Janicak PG
    Psychiatry Res; 1994 Jan; 51(1):51-60. PubMed ID: 7910975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
    Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
    J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
    [No Abstract]   [Full Text] [Related]  

  • 45. Biological relationships between mania and melancholia.
    Post RM; Uhde TW
    Encephale; 1982; 8(2):213-28. PubMed ID: 6179764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
    Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
    Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
    Liu HC; Yang JC; Chang YF; Liu TY; Chi CW
    Ann N Y Acad Sci; 1991; 640():215-8. PubMed ID: 1723257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refractoriness to lithium treatment in bipolar mania.
    Miller F; Tanenbaum JH; Griffin A; Ritvo E
    J Clin Psychopharmacol; 1990 Jun; 10(3):227. PubMed ID: 2115895
    [No Abstract]   [Full Text] [Related]  

  • 50. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
    Mooney JJ; Schatzberg AF; Cole JO; Samson JA; Waternaux C; Gerson B; Pappalardo KM; Schildkraut JJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):339-43. PubMed ID: 1770151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
    Walkup JT; Wagner KD; Miller L; Yenokyan G; Luby JL; Joshi PT; Axelson DA; Robb A; Salpekar JA; Wolf D; Sanyal A; Birmaher B; Vitiello B; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study.
    Kurita M; Nishino S; Numata Y; Okubo Y; Sato T
    PLoS One; 2014; 9(6):e100634. PubMed ID: 24971450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
    Hsiao JK; Agren H; Bartko JJ; Rudorfer MV; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1987 Dec; 44(12):1078-83. PubMed ID: 2446588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The switch process in manic-depressive psychosis.
    Ann Intern Med; 1977 Sep; 87(3):319-35. PubMed ID: 20015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pupillary cholinergic sensitivity to pilocarpine increases in manic lithium responders.
    Sokolski KN; DeMet EM
    Biol Psychiatry; 1999 Jun; 45(12):1580-4. PubMed ID: 10376118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid amine metabolites in acute schizophrenia.
    Post RM; Fink E; Carpenter WT; Goodwin FK
    Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new approach to biochemical evaluation of brain dopamine metabolism.
    Kopin IJ; White JH; Bankiewicz K
    Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.